• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    182.50 Down 7.26(3.83%) Sep 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:189.76
    Open:183.26
    Bid:180.10 x 100
    Ask:199.00 x 100
    1y Target Est:384.63
    Beta:-8.07776
    Earnings Date:Nov 5 - Nov 9 (Est.)
    Day's Range:181.00 - 188.50
    52wk Range:128.50 - 314.88
    Volume:382,648
    Avg Vol (3m):357,035
    Market Cap:4.42B
    P/E (ttm):N/A
    EPS (ttm):-7.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ICPT

    Comparison

    Symbol% ChgMkt Cap
    ICPTDown 3.83%4.42B
    AZNDown 1.89%77.58B
    SLXP 0.00%10.88B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,651.04
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-10.40
    Quarterly EPS Est (Sep-15) :-2.76
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-2.51

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback